Budget 2025: 36 Life-Saving Drugs Exempted From Custom Duty — Check Out Full List
Finance Minister Nirmala Sitharaman on Saturday announced the removal of custom duty on 36 drugs for cancer and rare diseases in the Union Budget 2025.
She said, "To provide relief to patients, particularly those suffering from cancer, rare diseases and other severe chronic diseases, I propose to add 36 life-saving drugs and medicines to the list of medicines fully exempted from basic customs duty."
She also proposed to add six life-saving medicines to list attracting concessional customs duty of 5%. Full exemption and concessional duty will also respectively apply for the bulk drugs for the manufacture of these drugs.
In addition, the government will exempt basic custom duty on 37 more drugs. Further the finance minister announced the launch of 200 cancer daycare centres that will be set up in government hospitals in all districts within the time span of three years.
Sitharaman has also said that the drugs and medicines under Patient Assistance Programmes run by pharmaceutical companies are fully exempt from the basis custom duty if these medicines are provided to the patients free of cost.
In a giant announcement for India's middle class, Finance Minister Nirmala Sitharaman, announced that there will be no income tax payable for income up to Rs 12 lakh. This comes as the biggest tax relief for the middle class since 1997.
The rebate goes up to Rs 12.75 lakh taking into account standard deductions, under the new tax regime, said the finance minister.
The new tax regime, made the default tax regime by the government, provides for concessional tax rates and liberal slabs. However, this regime doesn't provide the deductions that are allowed under the old tax regime.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.